Article
Stark Raving Health Unveils New Pro Bono Program to Amplify Voices of Small Advocacy Groups
Data-driven recruitment accelerates obesity drug trial by two months while surpassing diversity targets, showing how precision targeting can transform clinical research in the battle against America's growing health crisis.
More than 100 million Americans live with obesity today – a condition that dramatically increases their risk of heart disease, stroke, diabetes, and cancer. As this health crisis continues to grow, innovative clinical trials offer hope for those struggling with weight management.
Stark / Raving Health’s mission was clear: Connect qualified participants with a clinical trial examining an investigational weekly injectable obesity drug. Through strategic digital outreach, we exceeded recruitment targets while reducing cost-per-enrollment – demonstrating how patient-centric engagement can accelerate critical medical research.
The implications extend far beyond metrics. Each enrolled participant represents an individual seeking transformative change, and our success means accelerating access to potentially life-changing treatments. This case study reveals how reimagining patient engagement can not only drive clinical research efficiency but also help address one of health care’s most pressing challenges.
Drive Rapid Patient Enrollment
We aimed to identify and attract participants meeting the clinical study’s precise inclusions / exclusion criteria – specifically, individuals with a high BMI who were otherwise in good health. This unique combination required targeted outreach to reach the right candidates.
Build Study Awareness
Our strategy focused on educating potential participants about this potential weight loss option, emphasizing both the opportunity and the scientific rigor of the clinical trial process.
Generate Quality Patient Referrals
Beyond pure numbers, we needed to ensure referred candidates closely matched the study criteria to maintain high screening-to-enrollment ratios and accelerate the recruitment timeline.
Optimize Participant Screening
By developing highly specific targeting parameters, we worked to minimize screening burden on the site staff while maximizing the qualification rate of interested participants.
Comprehensive Audience Understanding
We developed detailed participant personas based on extensive demographic research, lifestyle patterns, and health behaviors. This multi-dimensional approach ensured our messaging resonated with diverse study participants – from busy professionals to active retiree – while maintaining strict adherence to study criteria.
Data-Driven Media Planning
Through rigorous pre-media launch analysis, we:
Cross-Channel Visibility Strategy
Our integrated approach leveraged:
Continuous Optimization
We implemented a dynamic feedback loop to:
Our precision-engineered campaign delivered exceptional results that redefined what’s possible in clinical trial recruitment:
Explosive Early Success
Cost-Efficient Patient Acquisition
True Representative Reach
This breakthrough performance demonstrates how data-driven media can accelerate clinical research while ensuring broad, inclusive participation. The campaign’s success has established new industry standards for efficient, diverse patient recruitment.
Through meticulous research and authentic storytelling, we crafted messages that deeply resonated with potential participants. This precision targeting, combined with compelling creative, didn’t just meet enrollment goals – it shattered them.
The numbers tell a powerful story: recruitment targets achieved months ahead of schedule, cost-effective participant acquisition, and a diverse participant pool that truly represents the communities this treatment aims to serve. But beyond the metrics lies an even more significant achievement: accelerating the path to potentially life-changing obesity treatment.
This campaign proves that when cutting-edge strategy meets deep audience understanding, we can dramatically accelerate clinical research timelines while maintaining the highest standards of participant quality. We’ve established a new benchmark for what’s possible in clinical trial recruitment – one that combines speed, precision, and inclusive representation.